Form 4 for LRCX Lam Research
Accepted 2021-09-16 00:00:00 ET · period of report 2021-09-15 · accession 0000707549-21-000145 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-16 | 2021-09-15 | LRCX | Meikle Scott Gerald | SVP | S - Sale+OE | $603.79 | -500 | 17.0K | -3% | -$301.9K |
| D | 2021-09-16 | 2021-09-15 | LRCX | Meikle Scott Gerald | SVP | M - OptEx | $190.70 | +500 | 17.5K | +3% | +$95.3K |
| D | 2021-09-16 | 2021-09-15 | LRCX | Meikle Scott Gerald | SVP | M - OptEx | $190.07 | -500 | 1,128 | -31% | -$95.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-15 | S | D | 500 | $603.79 | 17,024 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 11, 2021. (F2) The amount reported includes shares subject to unvested Restricted Stock Units. |
| 2 | Common | Common Stock | 2021-09-15 | M | A | 500 | $190.70 | 17,524 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 11, 2021. (F2) The amount reported includes shares subject to unvested Restricted Stock Units. |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2021-09-15 | M | D | 500 | $190.07 | 1,128 | D | $190.70 · — to 2025-03-01 | 500 Common Stock | (F3) The stock options will become exercisable in three equal installments on 03/01/2019, 03/01/2020, and 03/01/2021. |